FDA recall D-0829-2018

Mylan Pharmaceuticals Inc. · Class II · drug

Product

PrednisoLONE Sodium Phosphate Orally Disintegrating Tablets 10 mg, Rx Only, 48-count bottle, NDC 00378-4710-22

Reason for recall

CGMP Deviations

Distribution

Recalling firm distributed product to wholesalers throughout the United States, including Puerto Rico.

Key facts

Status
Terminated
Initiation date
2018-04-30
Report date
2018-05-30
Termination date
2019-02-14
Voluntary/Mandated
Voluntary: Firm initiated
Location
Morgantown, WV, United States

Primary source

https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0829-2018